“We must take a three-pronged approach to address the problem: diagnosis, prevention through vaccination and biosecurity of facilities”. Said by Dr. Paul Walz, of the College of Veterinary Medicine at Auburn University, Alabama, in the United States, during the 3rd International Congress of Bovine Viral Diarrhea Virus (BVDV) organized…
At this year’s event, which will be held under the theme “Impact and Management of BVD Virus in Cattle,” international experts will discuss strategies to control this disease and mitigate its impact on livestock. Next August 28 at 6:00 PM, the 3rd International Congress on Bovine Viral Diarrhea…
The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, was one of 4 finalists in its category among around 1,000 projects submitted at the 13th edition of the Pioneering Solutions Contest from Banco Nación, aimed at SMEs and enterprises….
Knowledge about the impact of this virus on production and control measures to mitigate its effect on the herd was disseminated at the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), convened by Bioinnovo and INTA. The Second International BVDV Congress, held virtually by…
In August, Bioinnovo will host the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), which will be held remotely. Bioinnovo, the public-private company made up of Vetanco and INTA, will host the Second International Congress on BVDV, which will be held online on Monday,…
Bioinnovo, comprised of Vetanco and IncuINTA (INTA‘s technical-organizational platform for the development of technological projects) is the first public-private Technology-Based biotechnology Company (TBC) and will be present at the Afrivet Technical Conference 2022 to be held on August 2 and 4 at the Protea Hotel Fire & Ice in Menlyn,…
Bioinnovo has participated in 2021 ISV Annual Virtual Congress by sharing experiences in the development of innovative veterinary vaccines to fight against several diseases, and by introducing the successful case of Vedevax Block, the first subunit recombinant vaccine in the world that has been approved…
The Workshop “BVDV Differential Diagnosis and Management Strategies” took place as part of the first International Congress on BVDV. Bioinnovo, the first public-private company created by Vetanco and the National Institute of Agricultural Technology (INTA), aimed at investigating, designing and developing IgY antibodies and recombinant vaccines, and at…
The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was held last Monday, August 2, and dealt with the different available vaccines and vaccination strategies to fight against this virus, responsible for millions of dollars in losses to national farms….
On Monday, July 12 the International Congress of Bovine Viral Diarrhea Virus (BVDV) was initiated addressing the problems raised by the disease in cattle as well as its enormous economic losses and alternatives for its control. Bioinnovo, the public-private company formed by Vetanco and INTA, has organized the First International Congress…